Elemental composition analysis of calcium-based urinary stones via laser-induced breakdown spectroscopy for enhanced clinical insights

利用激光诱导击穿光谱法分析钙基尿路结石的元素组成,以增强临床洞察力。

阅读:1

Abstract

The purpose of this study was to profile elemental composition of calcium-based urinary stones using laser-induced breakdown spectroscopy (LIBS) and develop a machine learning model to distinguish recurrence-associated profiles by integrating elemental and clinical data. A total of 122 calcium-based stones (41 calcium oxalate, 11 calcium phosphate, 49 calcium oxalate/calcium phosphate, 8 calcium oxalate/uric acid, 13 calcium phosphate/struvite) were analyzed via LIBS. Elemental intensity ratios (H/Ca, P/Ca, Mg/Ca, Sr/Ca, Na/Ca, K/Ca) were calculated using Ca (396.847 nm) as reference. Clinical variables (demographics, laboratory and imaging results, recurrence status) were retrospectively collected. A back propagation neural network (BPNN) model was trained using four data strategies: clinical-only, spectral principal components (PCs), combined PCs plus clinical, and merged raw spectral plus clinical data. The performance of these four models was evaluated. Sixteen stone samples from other medical centers were used as external validation sets. Mg and Sr were detected in most of stones. Significant correlations existed among P, Mg, Sr, and K ratios. Recurrent patients showed elevated elemental ratios (p < 0.01), higher urine pH (p < 0.01), and lower stone CT density (p = 0.044). The BPNN model with merged spectral plus clinical data achieved optimal performance in classification (test set accuracy: 94.37%), significantly outperforming clinical-only models (test set accuracy: 73.37%). The results of external validation indicate that the model has good generalization ability. LIBS reveals ubiquitous Mg and Sr in calcium-based stones and elevated elemental ratios in recurrent cases. Integration of elemental profiles with clinical data enables high-accuracy classification of recurrence-associated profiles, providing insights for potential risk stratification in urolithiasis management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。